“The current predicament has exposed some structural weaknesses within the EU’s medicines source chain and also a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that offer chain problems be addressed in an EU pharmaceutical approach envi… Read More